The genetic basis for cardiomyopathy: From mutation identification to mechanistic paradigms

Cell

Volumn 104, Issue 4, 2001, Pages 557-567

  Seidman, J G ^a   Seidman, Christine ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; CONNECTIN; MYOSIN BINDING PROTEIN C; MYOSIN HEAVY CHAIN; MYOSIN LIGHT CHAIN; TROPOMYOSIN; TROPONIN I; TROPONIN T;

CARDIOMYOPATHY; GENE DELETION; GENETIC HETEROGENEITY; HEART DILATATION; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MISSENSE MUTATION; MYOFILAMENT; NONHUMAN; PRIORITY JOURNAL; REVIEW; SARCOMERE;

EID: 0035936792     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(01)00242-2     Document Type: Review

References (65)

1. MLP-deficient mice exhibit a disruption of cardiac cytoarchitectural organization, dilated cardiomyopathy and heart failure
2. Enteroviral protease 2A cleaves dystrophin: Evidence of cytoskeletal disruption in an acquired cardiomyopathy
3. Mutations in the gene encoding lamin A/C cause autosomal dominant Emery-Dreifuss muscular dystrophy
4. Dilated cardiomyopathy
5. Mapping of a novel gene for familial hypertrophic cardiomyopathy to chromosome 11
6. Complexity in simplicity: Monogenic disorders and complex cardiomyopathies
7. Report of the National Heart, Lung and Blood Institute special emphasis panel on heart failure research
8. Disruption of the sarcoglycan-sarcospan complex in vascular smooth muscle: A novel mechanism for cardiomyopathy and muscular dystrophy
9. The in vivo motility activity of beta-cardiac myosin depends on the nature of the beta-myosin heavy chain gene mutation in hypertrophic cardiomyopathy
10. Crystal structure of a vertebrate smooth muscle myosin motor domain and its complex with the essential light chain: Visualization of the pre-power stroke state
11. Neonatal cardiomyopathy in mice homozygous for the Arg403Gln mutation in the α-cardiac myosin heavy chain gene
12. Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease
13. Hypertrophic cardiomyopathy
14. 2+ response in mutant sarcomere protein-mediated familial hypertrophic cardiomyopathy
15. Troponin: Structure, properties, and mechanism of functioning
16. A mouse model of familial hypertrophic cardiomyopathy
17. The nuclear envelope lamina is reversibly depolymerized during mitosis
18. Missense mutations in desmin associated with familial cardiac and skeletal myopathy
19. Isolation of a de novo mutant myocardial β MHC protein in a pedigree with hypertrophic cardiomyopathy
20. Frequency and phenotypes of familial dilated cardiomyopathy
21. Homozygous mutation in cardiac troponin T: Implications for hypertrophic cardiomyopathy
22. Endothelin and angiotensin II stimulation of Na+-H+ exchange is impaired in cardiac hypertrophy
23. The cardiac beta-myosin heavy chain gene is not the predominant gene for hypertrophic cardiomyopathy in the Finnish population
24. Mapping a gene for familial hypertrophic cardiomyopathy to chromosome 14q1
25. Sarcomere protein gene mutations cause dilated cardiomyopathy
26. Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy
27. Desmin mutation responsible for idiopathic dilated cardiomyopathy
28. 2+-release channel function
29. A transgenic rabbit model for human hypertrophic cardiomyopathy
30. Prevalence of hypertrophic cardiomyopathy in a general population of young adults: Echocardiographic analysis of 4111 subjects in the CARDIA study: Coronary artery risk development in (young) adults
31. Dilated cardiomyopathy in homozygous myosin-binding protein-C mutant mice
32. Familial dilated cardiomyopathy: Evidence for genetic and phenotypic heterogeneity
33. Disruption of muscle architecture and myocardial degeneration in mice lacking desmin
34. Chronic phospholamban-sarcoplasmic reticulum calcium ATPase interaction is the critical calcium cycling defect in dilated cardiomyopathy
35. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy
36. α-Cardiac actin is a novel disease gene in familial hypertrophic cardiomyopathy
37. Identification of mutations in the gene encoding lamins A/C in autosomal dominant limb girdle muscular dystrophy with conduction disturbances (LGMD1B)
38. Identification of the Syrian hamster cardiomyopathy gene
39. Possible gene dose effect of a mutant cardiac β-myosin heavy chain gene on the clinical expression of familial hypertrophic cardiomyopathy
40. Dominant-negative effect of a mutant cardiac troponin T on cardiac structure and function in transgenic mice
41. Evidence for a dystrophin missense mutation as a cause of X-linked dilated cardiomyopathy
42. Actin mutations in dilated cardiomyopathy, a heritable form of heart failure
43. Mutations in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscle
44. Structure of the actin-myosin complex and its implications for muscle contraction
45. Structural interpretation of the mutations in the β-cardiac myosin that have been implicated in familial hypertrophic cardiomyopathy
46. Identification of a contractile deficit in adult cardiac myocytes expressing hypertrophic cardiomyopathy-associated mutant troponin T proteins
47. Structural analysis of the titin gene in hypertrophic cardiomyopathy: Identification of a novel disease gene
48. Molecular diversity of myofibrillar proteins: Gene regulation and functional significance
49. Hypertrophic cardiomyopathy
50. Dilated cardiomyopathy and sensorineural hearing loss: A heritable syndrome that maps to 6q23-24
51. LMNA, encoding lamin A/C, is mutated in partial lipodystrophy
52. Three-dimensional atomic model of F-actin decorated with Dictyostelium myosin S1
53. The management of hypertrophic cardiomyopathy
54. Muscular dystrophies and the dystrophin-sarcoglycan protein complex
55. Nuclear lamins: Their structure, assembly and interactions
56. A truncated cardiac troponin T molecule in transgenic mice suggests multiple cellular mechanisms for familial hypertrophic cardiomyopathy
57. A familial hypertrophic cardiomyopathy locus maps to chromosome 15q2
58. Etiologies of cardiomyopathy and heart failure
59. Single molecule mechanics of R403Q cardiac myosin isolated from the mouse model of familial hypertrophic cardiomyopathy
60. Sporadic hypertrophic cardiomyopathy due to de novo myosin mutations
61. A disease locus for familial hypertrophic cardiomyopathy maps to chromosome 1q3
62. Expression and functional assessment of a truncated cardiac troponin T that cause hypertrophic cardiomyopathy: Evidence for a dominant negative action
63. A 35-A movement of smooth muscle myosin on ADP release
64. A mouse model of myosin binding protein C human familial hypertrophic cardiomyopathy
65. Alteration of intracellular Ca2(+)-handling and receptor regulation in hypertensive cardiac hypertrophy: Insights from Ren2-transgenic rats